Company intelligence / Profile preview
Gensco Laboratories
- Ownership
- Private
- Employees
- ~50
- Development stage
- Other
Overview
Gensco Laboratories is a specialty pharmaceutical company focused on the development and commercialization of prescription products for pain management and other therapeutic areas. The company specializes in topical delivery systems designed to improve patient compliance and safety compared to systemic treatments. Their portfolio includes branded products such as LiDORX, Terocin, and SpeedGel, which target conditions like neuropathic pain and musculoskeletal inflammation. Gensco emphasizes research-driven solutions to address unmet needs in the healthcare market through innovative drug delivery technologies.
- Therapeutic areas
- RheumatologyNeurology
- Modalities
- Small moleculeTopical
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on Gensco Laboratories.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gensco Laboratories.